Palisade Bio (PALI) Analyst & Key Data

Analyst Consensus

Buy2 analysts

Buy

Updated Sep 12, 2026

Total Analysts2

Buy

3

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score4.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$2.06

Median Target+118.45%

$4.50

Potential upside vs current price

DCF Value+15.86%

$2.39

Potential upside vs current price

Current Stock Price

$2.06

Median Target+118.45%

$4.50

Potential upside vs current price

DCF Value+15.86%

$2.39

Potential upside vs current price

Analyst Consensus

Buy2 analysts

Buy

Updated Sep 12, 2026

Total Analysts2

Buy

3

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score4.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$2.06

Median Target+118.45%

$4.50

Potential upside vs current price

DCF Value+15.86%

$2.39

Potential upside vs current price

Current Stock Price

$2.06

Median Target+118.45%

$4.50

Potential upside vs current price

DCF Value+15.86%

$2.39

Potential upside vs current price

Palisade Bio, Inc.